prediction of human responses before clinical trials. myotwin works with pharmaceutical and biotech clients as a contract research partner, integrating organoid assays into preclinical pipelines. The offering centers on standardized assay design, data acquisition, and interpretation tailored to research and development decisions. By emphasizing human-relevant test systems, myotwin aims to reduce reliance on animal studies and streamline selection of promising therapeutic candidates.